You can buy or sell GTHX and other stocks, options, ETFs, and crypto commission-free!
G1 Therapeutics, Inc. Common Stock, also called G1 Therapeutics, is a clinical-stage biopharmaceutical company that focuses on the discovery and development of novel therapies to address significant unmet needs in oncology. Read More The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.
Research Triangle Park, North Carolina
52 Week High
52 Week Low
Simply Wall StMar 14
The G1 Therapeutics (NASDAQ:GTHX) Share Price Is Down 57% So Some Shareholders Are Wishing They Sold
Even the best stock pickers will make plenty of bad investments. And unfortunately for G1 Therapeutics, Inc. (NASDAQ:GTHX) shareholders, the stock is a lot lower today than it was a year ago. The share price is down a hefty 57% in that time. We wouldn’t rush to judgement on G1 Therapeutics because we don’t have a long term history to look at. The falls have accelerated recently, with the share price down 46% in the last three months. This could be related to the recent financial results – you can catch up o...
Trump Administration Makes Surprising Choice for FDA Interim Chief: a Career Scientist
Norman “Ned” Sharpless was named as interim head of the Food and Drug Administration Tuesday. Sharpless, the director of the National Cancer Institute, is a scientist, making the appointment a departure from the Trump administration’s pattern of appointing industry insiders and lobbyists to head federal agencies. Sharpless has served as the director of the NCI since October 2017. He also heads the aging biology and cancer section of the National Institute on Aging’s Laboratory of Genetics and Genomics. His...
Expected May 2, After Hours